Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen P Pratt

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Current Opinion in Hematology|July 21, 2012
Inhibitory antibodies in hemophilia AKathleen P Pratt
Blood|July 20, 2023
Factor VIII forges its own pathKathleen P Pratt
Antibodies (Basel, Switzerland)|September 24, 2019
Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic ImmunogenicityKathleen P Pratt
Cellular Immunology|November 14, 2015
Engineering less immunogenic and antigenic FVIII proteinsKathleen P Pratt
Blood|September 5, 2015
fVIII binds platelets + fibrin: no PS!Kathleen P Pratt
Blood|December 9, 2017
Marginal immunogenicity of factor VIIIKathleen P Pratt
Blood|April 27, 2013
Presenting ADAMTS13 on a TTP-associated MHCKathleen P Pratt
Blood Advances|April 28, 2026
Investigative reporting on factor VIII whereaboutsKathleen P Pratt
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Race, ethnicity, F8 variants, and inhibitor risk: analysis of the "My Life Our Future" hemophilia A databaseAnwar E Ahmed, Kathleen P Pratt
Frontiers in Immunology|February 11, 2021
Editorial: Tolerating Factor VIII: Novel Strategies to Prevent and Reverse Neutralizing Anti-FVIII AntibodiesSébastien Lacroix-Desmazes, Kathleen P Pratt
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Current Opinion in Hematology|July 21, 2012
Inhibitory antibodies in hemophilia AKathleen P Pratt
Blood|July 20, 2023
Factor VIII forges its own pathKathleen P Pratt
Antibodies (Basel, Switzerland)|September 24, 2019
Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic ImmunogenicityKathleen P Pratt
Cellular Immunology|November 14, 2015
Engineering less immunogenic and antigenic FVIII proteinsKathleen P Pratt
Blood|September 5, 2015
fVIII binds platelets + fibrin: no PS!Kathleen P Pratt
Blood|December 9, 2017
Marginal immunogenicity of factor VIIIKathleen P Pratt
Blood|April 27, 2013
Presenting ADAMTS13 on a TTP-associated MHCKathleen P Pratt
Blood Advances|April 28, 2026
Investigative reporting on factor VIII whereaboutsKathleen P Pratt
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Race, ethnicity, F8 variants, and inhibitor risk: analysis of the "My Life Our Future" hemophilia A databaseAnwar E Ahmed, Kathleen P Pratt
Frontiers in Immunology|February 11, 2021
Editorial: Tolerating Factor VIII: Novel Strategies to Prevent and Reverse Neutralizing Anti-FVIII AntibodiesSébastien Lacroix-Desmazes, Kathleen P Pratt
Pageof 6